Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ATAPAC Study (TauroLock Activity in Adult Cancer Patients)

NCT: NCT02279121 · COMPLETED

NCT IDNCT02279121
StatusCOMPLETED
SponsorCentre Hospitalier Régional Metz-Thionville (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to compare the efficacy of a lock taurolidine-citrate solution vs standard saline solution for primary prevention of central venous catheter-associated bloodstream infection in adult patients treated with intra-venous therapy for a solid tumor

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑